APA

Qu C., Li Y., Li Y., Yu P., Li P., Donkers J. M., van de Graaf S. F. J., de Man R. A., Peppelenbosch M. P. & Pan Q. (20200727). FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis. : Antiviral research.

Chicago

Qu Changbo, Li Yang, Li Yunlong, Yu Peifa, Li Pengfei, Donkers Joanne M, van de Graaf Stan F J, de Man Robert A, Peppelenbosch Maikel P and Pan Qiuwei. 20200727. FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis. : Antiviral research.

Harvard

Qu C., Li Y., Li Y., Yu P., Li P., Donkers J. M., van de Graaf S. F. J., de Man R. A., Peppelenbosch M. P. and Pan Q. (20200727). FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis. : Antiviral research.

MLA

Qu Changbo, Li Yang, Li Yunlong, Yu Peifa, Li Pengfei, Donkers Joanne M, van de Graaf Stan F J, de Man Robert A, Peppelenbosch Maikel P and Pan Qiuwei. FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis. : Antiviral research. 20200727.